Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma

被引：4

作者：

Sekiya, Sho ^{[1
,2
]}

Fukuda, Junki ^{[1
,2
]}

Yamamura, Ryodai ^{[1
]}

Ooshio, Takako ^{[1
]}

Satoh, Yusuke ^{[1
]}

Kosuge, Shinya ^{[1
,2
]}

Sato, Reo ^{[1
]}

Hatanaka, Kanako C. ^{[3
]}

Hatanaka, Yutaka ^{[3
,4
]}

Mitsuhashi, Tomoko ^{[5
]}

Nakamura, Toru ^{[2
]}

Matsuno, Yoshihiro ^{[5
]}

Hirano, Satoshi ^{[2
]}

Sonoshita, Masahiro ^{[1
,6
]}

机构：

[1] Hokkaido Univ, Inst Genet Med, Div Biomed Oncol, Sapporo 0600815, Japan

[2] Hokkaido Univ, Fac Med, Dept Gastroenterol Surg 2, Sapporo, Japan

[3] Hokkaido Univ Hosp, Ctr Dev Adv Diagnost, Sapporo, Japan

[4] Hokkaido Univ Hosp, Res Div Genome Compan Diagnost, Sapporo, Japan

[5] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Japan

[6] Hokkaido Univ, Global Stn Biosurfaces & Drug Discovery, Sapporo 0600812, Japan

来源：

CANCER RESEARCH | 2023年 / 83卷 / 16期

基金：

日本学术振兴会; 日本科学技术振兴机构;

关键词：

PHASE-1; DOSE-ESCALATION; AURORA-B; CANCER; KINASE; TRAMETINIB; COOPERATE; GEMCITABINE; PROGRESSION; EXPRESSION; KRAS(G12D);

D O I：

10.1158/0008-5472.CAN-22-3762

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Significant progress has been made in understanding the pathogenesis of pancreatic ductal adenocarcinoma (PDAC) by generating and using murine models. To accelerate drug discovery by identifying novel therapeutic targets on a systemic level, here we generated a Drosophila model mimicking the alterations), which is associated with the worst prognosis in patients. The '4-hit' flies displayed epithelial transformation and decreased survival. Comprehensive genetic screening of their entire kinome revealed kinases including MEK and AURKB as therapeutic targets. Consistently, a combination of the MEK

引用

页码：2704 / 2715

页数：12

共 50 条

[1] Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition
Brannon, Arthur, III
Drouillard, Donovan
Steele, Nina
Schoettle, Shadae
Abel, Ethan V.
Crawford, Howard C.
Pasca di Magliano, Marina
SCIENTIFIC REPORTS, 2020, 10 (01)
[2] Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition
Arthur Brannon
Donovan Drouillard
Nina Steele
Shadae Schoettle
Ethan V. Abel
Howard C. Crawford
Marina Pasca di Magliano
Scientific Reports, 10
[3] Combined Proteasome and MEK Inhibition Results in Enhanced Growth Inhibition of Patient-derived Pancreatic Ductal Adenocarcinoma
Newhook, T.
Lindberg, J. M.
Adair, S. J.
Kim, A. J.
Parsons, J.
Bauer, T.
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S156 - S156
[4] Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma?
Krell, Jonathan
Frampton, Adam E.
Jiao, Long R.
Stebbing, Justin
PHARMACOGENOMICS, 2012, 13 (09) : 977 - 979
[5] Identification of novel therapeutic targets for pancreatic ductal adenocarcinoma through Drosophila phenotypic screening
Sonoshita, M.
EUROPEAN JOURNAL OF CANCER, 2024, 211 : S154 - S154
[6] Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
Karimnia, Vida
Slack, Frank J.
Celli, Jonathan P.
CANCERS, 2021, 13 (17)
[7] CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma
Cheng, Ke
Zhou, Zijian
Chen, Qiangxing
Chen, Zixin
Cai, Yu
Cai, He
Wu, Shangdi
Gao, Pan
Cai, Yunqiang
Zhou, Jin
Wang, Xin
Wu, Zhong
Peng, Bing
SCIENTIFIC REPORTS, 2024, 14 (01)
[8] More effective therapies for pancreatic ductal adenocarcinoma
不详
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (01) : 15 - 15
[9] The Dual Role of Necroptosis in Pancreatic Ductal Adenocarcinoma
Giansante, Valentina
Stati, Gianmarco
Sancilio, Silvia
Guerra, Emanuela
Alberti, Saverio
Di Pietro, Roberta
Hoheisel, Joerg D.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
[10] Screening for pancreatic ductal adenocarcinoma in the population with diabetes
Sharp, Patrick
Brown, Beata
Price, Hermione
PRACTICAL DIABETES, 2021, 38 (01) : 37 - U29

← 1 2 3 4 5 →